Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. More Details
Excellent balance sheet with solid track record.
Share Price & News
How has Sharps Compliance's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SMED is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: SMED's weekly volatility (9%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: SMED exceeded the US Healthcare industry which returned 43.7% over the past year.
Return vs Market: SMED exceeded the US Market which returned 50.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Sharps Compliance's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall StAre Investors Undervaluing Sharps Compliance Corp. (NASDAQ:SMED) By 39%?
3 weeks ago | Simply Wall StIs Sharps Compliance's (NASDAQ:SMED) 221% Share Price Increase Well Justified?
1 month ago | Simply Wall StDo Its Financials Have Any Role To Play In Driving Sharps Compliance Corp.'s (NASDAQ:SMED) Stock Up Recently?
Is Sharps Compliance undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SMED ($16.18) is trading below our estimate of fair value ($25.11)
Significantly Below Fair Value: SMED is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SMED is poor value based on its PE Ratio (26.7x) compared to the US Healthcare industry average (23.2x).
PE vs Market: SMED is poor value based on its PE Ratio (26.7x) compared to the US market (20.2x).
Price to Earnings Growth Ratio
PEG Ratio: SMED's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: SMED is overvalued based on its PB Ratio (6.9x) compared to the US Healthcare industry average (3.6x).
How is Sharps Compliance forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SMED's earnings are forecast to decline over the next 3 years (-4.6% per year).
Earnings vs Market: SMED's earnings are forecast to decline over the next 3 years (-4.6% per year).
High Growth Earnings: SMED's earnings are forecast to decline over the next 3 years.
Revenue vs Market: SMED's revenue (4.7% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: SMED's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SMED's Return on Equity is forecast to be high in 3 years time
How has Sharps Compliance performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SMED has a high level of non-cash earnings.
Growing Profit Margin: SMED's current net profit margins (14.2%) are higher than last year (1.2%).
Past Earnings Growth Analysis
Earnings Trend: SMED's earnings have grown significantly by 72.7% per year over the past 5 years.
Accelerating Growth: SMED's earnings growth over the past year (1586.6%) exceeds its 5-year average (72.7% per year).
Earnings vs Industry: SMED earnings growth over the past year (1586.6%) exceeded the Healthcare industry 42.3%.
Return on Equity
High ROE: SMED's Return on Equity (25.6%) is considered high.
How is Sharps Compliance's financial position?
Financial Position Analysis
Short Term Liabilities: SMED's short term assets ($39.5M) exceed its short term liabilities ($18.8M).
Long Term Liabilities: SMED's short term assets ($39.5M) exceed its long term liabilities ($12.1M).
Debt to Equity History and Analysis
Debt Level: SMED's debt to equity ratio (16.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if SMED's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: SMED's debt is well covered by operating cash flow (102.9%).
Interest Coverage: SMED's interest payments on its debt are well covered by EBIT (61.2x coverage).
What is Sharps Compliance current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SMED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SMED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SMED's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SMED's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SMED's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David Tusa (60 yo)
Mr. David P. Tusa, CPA, has been the President of Sharps Compliance Corp. since June 14, 2010 and as its Chief Executive Officer since September 30, 2010. Mr. Tusa served as the Chief Financial Officer of ...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD371.18K) is below average for companies of similar size in the US market ($USD1.02M).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
Experienced Management: SMED's management team is seasoned and experienced (6.5 years average tenure).
Experienced Board: SMED's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SMED insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.3%.
Sharps Compliance Corp.'s company bio, employee growth, exchange listings and data sources
- Name: Sharps Compliance Corp.
- Ticker: SMED
- Exchange: NasdaqCM
- Founded: 1992
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$273.289m
- Shares outstanding: 16.89m
- Website: https://www.sharpsinc.com
Number of Employees
- Sharps Compliance Corp.
- 9220 Kirby Drive
- Suite 500
- United States
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/08 23:02|
|End of Day Share Price||2021/05/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.